Covid-19 vaccination: The current study shows that antibody levels in recipients of the Moderna vaccine have been comparatively larger than in these recipients of the Pfizer vaccine. The findings have been published not too long ago in JAMA Network Open and the study was performed by researchers from the University of Virginia School of Medicine on antibody response generated by the Pfizer and Moderna vaccines.
The scientists have also noted that one will have to not look at antibody numbers as a basis of vaccines’ effectiveness, as quoted in the press release issued by the University of Virginia. Although each vaccines have shown phenomenal overall performance, the new findings are considerable as these will aid establish whether or not one vaccine is superior to the other in specific places.
In the study, blood samples have been received from 167 University staff who have been vaccinated against covid 19. Out of them, 79 have received Pfizer when 88 have received the Moderna vaccine. The researchers, general, located that Moderna developed more antibodies in the blood just after finding the second dose than Pfizer. While Moderna developed some68.5 micrograms of antibodies per milliliter of blood, Pfizer developed only 45.9 micrograms of antibodies per milliliter of blood.
A equivalent study comparing the immune response of the two vaccines–Moderna and Pfizer showed that two doses of Moderna vaccine produces more antibodies than these who are vaccinated totally with Pfizer vaccine. Both the vaccines use the mRNA technologies and are getting employed broadly in a number of nations. The findings have been published in a letter to the Journal of the American Medical Association on August 30.
The study showed that the ones who have been infected with the virus when inoculated with the Moderna vaccine developed an antibody response of 2,881 units/ml and just 108 units/m antibody response when provided Pfizer. Even amongst these who have been previously infected with COVID, when provided Moderna shot showed larger presence of antibody compared to these who received the Pfizer vaccine.